923 Intrahepatic Cholestasis of Pregnancy and Preexisting and Future Hepatobiliary Diseases: A Population-Based Cohort Study of 125,281 Swedish Women Shows a Strong Association With Hepatitis C

2013 ◽  
Vol 144 (5) ◽  
pp. S-966-S-967
Author(s):  
Hanns-Ulrich Marschall ◽  
Elisabeth A. Wikström Shemer ◽  
Jonas F. Ludvigsson ◽  
Olof Stephansson
2015 ◽  
Vol 63 (2) ◽  
pp. 456-461 ◽  
Author(s):  
Elisabeth A. Wikström Shemer ◽  
Olof Stephansson ◽  
Marcus Thuresson ◽  
Malin Thorsell ◽  
Jonas F. Ludvigsson ◽  
...  

Hepatology ◽  
2013 ◽  
Vol 58 (4) ◽  
pp. 1385-1391 ◽  
Author(s):  
Hanns-Ulrich Marschall ◽  
Elisabeth Wikström Shemer ◽  
Jonas F. Ludvigsson ◽  
Olof Stephansson

Author(s):  
Suvi Tuulia Hamalainen ◽  
Kaisa Turunen ◽  
Kari J Mattila ◽  
Elise Kosunen ◽  
Markku Sumanen

2017 ◽  
Vol 07 (04) ◽  
pp. e223-e225 ◽  
Author(s):  
Adam Covach ◽  
William Rose

Objectives We report on a patient suffering from intractable itching secondary to intrahepatic cholestasis of pregnancy (ICP) unresponsive to conventional medical therapies. She was started on a regimen of therapeutic plasma exchange (TPE), which is often efficacious in relieving patient's itching from all causes of cholestasis, including ICP. Methods We performed a retrospective review of a patient's medical record. Results Following initial TPE, the patient reported dramatic relief of her itching and consequent insomnia. However, this effect was short lived, as subsequent TPE provided minimal relief, and may have actually worsened her itching. Out of concern for poor fetal outcomes, delivery was induced at 34 weeks gestational age. The child had an uncomplicated neonatal intensive care unit stay following delivery, and the mother reported > 90% relief of her symptoms 2 weeks after delivery. Conclusion TPE often provides longer term relief of itching because of ICP; however, it is not a panacea for these symptoms, and sometimes only delivery of the fetus can relieve maternal symptoms. In addition to the refractoriness to TPE, the case is also unusual for the early onset of ICP symptoms and the comorbidity of hepatitis C.


2021 ◽  
pp. 1753495X2110583
Author(s):  
Sawsan Al-Obaidly ◽  
Husam Salama ◽  
Tawa Olukade ◽  
Mai AlQubaisi ◽  
Arabo Bayo ◽  
...  

Background Intrahepatic cholestasis of pregnancy (ICP) is a complex liver disease with varying incidence worldwide. We compared ICP incidence and pregnancy outcomes with outcomes for normal pregnant controls. Methods We conducted a retrospective data analysis of perinatal registry data for the years 2011 and 2017 to compare the following outcome measures: stillbirths, labour induction, gestational diabetes, pre-eclampsia, antepartum haemorrhage, postpartum haemorrhage, preterm births, low Apgar score, acute neonatal respiratory morbidity, meconium aspiration and in-hospital neonatal death. Results The incidence of ICP was 8 per 1000 births from a total 31,493 singleton births with more cases in 2017 than in 2011. Women with ICP were almost six times more likely to have labour induced including significantly more moderate preterm births (defined as between 32 weeks and 36 weeks and 6 days of gestation)) seen more in 2011 than in 2017. Conclusion Women with ICP showed higher incidence of moderate preterm birth and induced labour but favourable maternal and neonatal outcomes.


Sign in / Sign up

Export Citation Format

Share Document